Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase von Muller, Alexander J, Sharma, Madhav D, Chandler, Phillip R, DuHadaway, James B, Everhart, Mary E, Johnson, Burles A. III, Kahler, David J, Pihkala, Jeanene, Soler, Alejandro Peralta, Munn, David H, Prendergast, George C, Mellor, Andrew L

Volltext

Targeting neoantigens to augment antitumour immunity von Yarchoan, Mark, Johnson, Burles A., Lutz, Eric R., Laheru, Daniel A., Jaffee, Elizabeth M.

Volltext

B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase von Johnson, Burles A. III, Kahler, David J, Baban, Babak, Chandler, Phillip R, Kang, Baolin, Shimoda, Michiko, Koni, Pandelakis A, Pihkala, Jeanene, Vilagos, Bojan, Busslinger, Meinrad, Munn, David H, Mellor, Andrew L

Volltext

Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome Analysis von Johnson III, Burles A., Teply, Benjamin A., Kagemann, Catherine, McGuire, Bridget, Lombardo, Kara, Jing, Yuezhou, Langbo, William, Epstein, Jonathan I., Netto, George J., Baras, Alex S., Matoso, Andres, McConkey, David J., Gupta, Amol, Ahuja, Nita, Ross, Ashley E., Pierorazio, Phillip M., Comperat, Eva, Hoffman-Censits, Jean, Singla, Nirmish, Patel, Sunil H., Kates, Max, Choi, Woonyoung, Bivalacqua, Trinity J., Hahn, Noah M.

Volltext

Targeting neoantigens to augment antitumour immunity von Yarchoan, Mark, Johnson, 3rd, Burles A, Lutz, Eric R, Laheru, Daniel A, Jaffee, Elizabeth M

Volltext

Strategies for Increasing Pancreatic Tumor Immunogenicity von Johnson, 3rd, Burles A, Yarchoan, Mark, Lee, Valerie, Laheru, Daniel A, Jaffee, Elizabeth M

Volltext

Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer model von Steinmetz, Alexis R, Pierce, Morgan, Martini, Alberto, Tholomier, Come, Manyam, Ganiraju, Chen, Yan, Sood, Akshay, Duplisea, Jonathan J, Johnson, Burles A, Czerniak, Bogdan A, Lee, Byron H, Jagannath, Chinnaswamy, Yla-Herttuala, Seppo, Parker, Nigel R, McConkey, David J, Dinney, Colin P, Mokkapati, Sharada

Volltext

Enfortumab vedotin-related cutaneous toxicity correlates with overall survival in patients with urothelial cancer: a retrospective experience von Vlachou, Evangelia, Johnson, Burles Avner, McConkey, David, Jing, Yuezhou, Matoso, Andres, Hahn, Noah M, Hoffman-Censits, Jean

Volltext

Racial Differences in Cutaneous Events Among Patients Receiving Enfortumab Vedotin von Vlachou, Evangelia, Mamtani, Ronac, Hahn, Noah M., III, Burles Johnson, Hoffman-Censits, Jean, Nimgaonkar, Vivek

Volltext